Phase 3 trial of subcutaneous epcoritamab plus R-CHOP versus R-CHOP in patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL): EPCORE DLBCL-2.

被引：0
|
作者：
Sehn, Laurie Helen
Chamuleau, Martine
Lenz, Georg
Clausen, Michael
Haioun, Corinne
Izutsu, Koji
Davies, Andrew John John
Zhu, Jun
Oki, Toshiko
Szafer-Glusman, Edith
Conlon, Rebekah
Chiou, Hueiyu
Ipe, David
Elliott, Brian
Wu, Jun
Salles, Gilles A.
机构：
[1] BC Canc Ctr Lymphoid Canc, Vancouver, BC, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
[3] Vrije Univ, Amsterdam Univ Med Ctr, Amsterdam, Netherlands
[4] Univ Hosp Munster, Munster, Germany
[5] Vejle Hosp, Vejle, Denmark
[6] Hop Henri Mondor, Creteil, France
[7] Natl Canc Ctr, Tokyo, Japan
[8] Univ Southampton, Southampton NIHR Canc Res UK Expt Canc Med, Southampton, Hants, England
[9] Beijing Canc Hosp, Beijing, Peoples R China
[10] AbbVie Inc, N Chicago, IL USA
[11] Genmab, Plainsboro, NJ USA
[12] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS7592
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Combination of everolimus with R-CHOP (ever R-CHOP) as an initial therapy for diffuse large B-cell lymphoma (DLBCL): A phase I and feasibility study (NCCTG N1085 [Alliance]).
    Johnston, Patrick B.
    LaPlant, Betsy
    Nowakowski, Grzegorz S.
    Micallef, Ivana N. M.
    Ansell, Stephen Maxted
    Habermann, Thomas Matthew
    Colgan, Joseph
    Witzig, Thomas E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma
    Nowakowski, Grzegorz S.
    Chiappella, Annalisa
    Gascoyne, Randy D.
    Scott, David W.
    Zhang, Qingyuan
    Jurczak, Wojciech
    Ozcan, Muhit
    Hong, Xiaonan
    Zhu, Jun
    Jin, Jie
    Belada, David
    Bergua, Juan Miguel
    Piazza, Francesco
    Mocikova, Heidi
    Molinari, Anna Lia
    Yoon, Dok Hyun
    Cavallo, Federica
    Tani, Monica
    Yamamoto, Kazuhito
    Izutsu, Koji
    Kato, Koji
    Czuczman, Myron
    Hersey, Sarah
    Kilcoyne, Adrian
    Russo, Jacqueline
    Hudak, Krista
    Zhang, Jingshan
    Wade, Steve
    Witzig, Thomas E.
    Vitolo, Umberto
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (12) : 1317 - +
  • [23] A randomized, phase 2 study of R-CHOP plus enzastaurin vs R-CHOP in patients with intermediate- or high-risk diffuse large B-cell lymphoma
    Hainsworth, John D.
    Arrowsmith, Edward R.
    McCleod, Michael
    Hsi, Eric D.
    Hamid, Oday
    Shi, Peipei
    Lin, Boris K.
    Fayad, Luis E.
    LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 216 - 218
  • [24] Epcoritamab versus standard of care in patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) - a phase 3 study (EPCORE DLBCL-1)
    Hess, G.
    Thieblemont, C.
    Clausen, M. R.
    Lugtenburg, P.
    Balari, Sureda A.
    Zinzani, P. L.
    Wu, J.
    Finn, L.
    Vindelov, S. D.
    Fox, C. P.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 192 - 193
  • [25] A Phase II Study of Chidamide Plus R-CHOP in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: An Interim Analysis
    Xu, Pengpeng
    Zhang, Muchen
    Fang, Ying
    Wang, Li
    Cheng, Shu
    Zhao, Wei-li
    BLOOD, 2017, 130
  • [26] PROGNOSTIC SIGNIFICANCE OF SARCOPENIA IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RITUXIMAB PLUS CHOP (R-CHOP)
    Go, S. I.
    Park, M. J.
    Kim, H. G.
    Kang, M. H.
    Lee, G. W.
    HAEMATOLOGICA, 2016, 101 : 686 - 687
  • [27] A Propensity Score-Adjusted Comparison of Lenalidomide plus R-CHOP Versus R-CHOP for MYC-Rearranged DLBCL Patients
    de Jonge, A. Vera
    van Werkhoven, Erik D.
    Dinmohamed, Avinash G.
    Nijland, Marcel
    Zwinderman, Aeilko H.
    Bossuyt, Patrick M.
    Veldhuis, Martine S.
    Rutten, Emma G. G. M.
    Mous, Rogier
    Vermaat, Joost S. P.
    Sandberg, Yorick
    de Jongh, Eva
    Bilgin, Yavuz M.
    Boersma, Rinske
    Koene, Harry R.
    Kersten, Marie Jose
    de Jong, Daphne
    Chamuleau, Martine E. D.
    BLOOD, 2022, 140 : 2059 - 2060
  • [28] R-CHOP compared with CHOP in patients with diffuse large B-cell lymphoma (DLCL): Russian experience
    Poddubnaya, I.
    Osmanov, E.
    Babicheva, L.
    Tumyan, G.
    Sorokin, E.
    Stefanov, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] Orelabrutinib Plus R-CHOP Regimen in Treatment-Naive Patients with TP53-Mutated Diffuse Large B-Cell Lymphoma (DLBCL)
    Xiao, Yi
    Wu, Jiaying
    Zhou, Mi
    Shang, Zhen
    Zhu, Ming
    BLOOD, 2023, 142
  • [30] SERUM B2-MICROGLOBULIN LEVELS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): PROGNOSTIC SIGNIFICANCE UNDER TREATMENT WITH RITUXIMAB-CHOP (R-CHOP)
    Vassilakopoulos, T. P.
    Anastasopoulou, A.
    Constantinou, N.
    Angelopoulou, M. K.
    Stavroulaki, E.
    Kalpadakis, C.
    Sachanas, S.
    Pappis, V.
    Tsirkinidis, P.
    Moschoyiannis, M.
    Tsopra, O.
    Tzenou, T.
    Gassiamis, A.
    Yiakoumis, X.
    Kyrtsonis, M. C.
    Kokoris, S. I.
    Siakantaris, M. P.
    Dimou, M.
    Georgiou, G.
    Plata, E.
    Viniou, N. A.
    Variamis, E.
    Konstantopoulos, K.
    Panayiotidis, P.
    Papadaki, H.
    Pangalis, G. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 393 - 394
12345